Clinical Trial
Published on 19 Apr 2024
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers
in Cancer Molecular Targets and Therapeutics
- 302 views
Clinical Trial
Published on 19 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 18 Apr 2024
in Cancer Molecular Targets and Therapeutics
Brief Research Report
Published on 18 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Accepted on 16 Apr 2024
in Cancer Molecular Targets and Therapeutics
Perspective
Accepted on 15 Apr 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 15 Apr 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 08 Apr 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 04 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 28 Mar 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Mar 2024
in Cancer Molecular Targets and Therapeutics
Retraction
Published on 20 Mar 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 14 Mar 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 14 Mar 2024
in Cancer Molecular Targets and Therapeutics
Case Report
Published on 11 Mar 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 08 Mar 2024
in Cancer Molecular Targets and Therapeutics
Mini Review
Published on 07 Mar 2024
in Cancer Molecular Targets and Therapeutics